This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Articles

Loss of Antidepressant Efficacy During Maintenance Therapy: Possible Mechanisms and Treatments

Sarah E. Byrne and Anthony J. Rothschild

Published: June 15, 1998

Article Abstract

Background: Many patients with unipolardepression experience a return of depressive symptoms whiletaking a constant maintenance dose of an antidepressant.

Method: All cited studies were found usingcomputerized literature searches of the MEDLINE database since1966.

Results: The return of depressive symptomsduring maintenance antidepressant treatment has occurred in 9% to57% of patients in published trials. Possible explanationsinclude loss of placebo effect, pharmacologic tolerance, increasein disease severity, change in disease pathogenesis, theaccumulation of a detrimental metabolite, unrecognized rapidcycling, and prophylactic inefficacy.

Conclusion: Although several strategies havebeen proposed to overcome the loss of antidepressant efficacy,double-blind controlled studies are needed to ascertain theoptimal strategy for this perplexing clinical problem.

Volume: 59

Quick Links: Depression (MDD)

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...